JCR Pharmaceuticals Co., Ltd. (TYO:4552)

Japan flag Japan · Delayed Price · Currency is JPY
623.00
+3.00 (0.48%)
At close: Mar 6, 2026
17.99%
Market Cap 76.00B
Revenue (ttm) 37.55B
Net Income (ttm) -2.44B
Shares Out 121.99M
EPS (ttm) -20.00
PE Ratio n/a
Forward PE 42.98
Dividend 20.00 (3.21%)
Ex-Dividend Date Mar 30, 2026
Volume 489,200
Average Volume 630,510
Open 611.00
Previous Close 620.00
Day's Range 607.00 - 625.00
52-Week Range 386.00 - 824.00
Beta 0.00
RSI 40.66
Earnings Date May 8, 2026

About JCR Pharmaceuticals

JCR Pharmaceuticals Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan. It offers various therapeutic products, including GROWJECT used for the treatment of growth hormone deficiency and short stature; IZCARGO to treat Mucopolysaccharidosis type II; Agalsidase Beta BS I.V. Infusion used for the treatment of Fabry disease; and TEMCELL HS Inj used to treat acute graft-versus-host disease. The comp... [Read more]

Sector Healthcare
Founded 1975
Employees 987
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4552
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.